Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters











Database
Publication year range
1.
J Ocul Pharmacol Ther ; 24(5): 445-51, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18788994

ABSTRACT

PURPOSE: The aim of this study was to investigate the effect of mutant of acidic fibroblast growth factor (MaFGF) on N-methyl-N-nitrosourea (MNU)-induced retinal degeneration in Sprague-Dawley rats. METHODS: Fifty (50)-day-old female Sprague-Dawley rats were given a single intraperitoneal injection of normal saline (NS) or 60 mg x kg(-1) body weight of MNU, and then NS or different doses of MaFGF were injected intravitreally twice at 0 and 12 h after NS or MNU treatment. After NS or MNU treatment for different times, the apoptotic index of the photoreceptor cell was detected by TUNEL labeling, whereas the mRNA expressions and the protein levels of antiapoptotic Bcl-2 and proapoptotic Bax were determined by reverse transcriptase polymerase chain reaction and Western blotting, respectively. Retinal damage was evaluated based on retinal thickness. RESULTS: MNU-induced retinal damage was partially protected by MaFGF in a dose-independent manner in rats. MaFGF at doses of 1.25 and 2.5 microg could partially suppress photoreceptor cell loss, whereas MaFGF at a dose of 5.0 mug had no protective effect on photoreceptor cell. The apoptotic index at 24 h post-MNU in the peripheral retina was 38.1 +/- 3.6%, whereas 1.25 and 2.5 mug MaFGF markedly reduced it to 27.5 +/- 2.0 and 21.1 +/- 1.9% (P = <0.001), respectively. As compared with the MNU-treated group, MaFGF significantly upregulated the expression of Bcl-2 mRNA and protein and downregulated the expression of Bax mRNA and protein (P = <0.001). CONCLUSION: MaFGF could counteract MNU-induced retinal damage and may be a therapeutic agent for the treatment of retinal degeneration.


Subject(s)
Fibroblast Growth Factor 1/pharmacology , Protective Agents/pharmacology , Retina/pathology , Retinal Degeneration/prevention & control , Animals , Apoptosis/drug effects , Blotting, Western , Dose-Response Relationship, Drug , Female , Fibroblast Growth Factor 1/genetics , Methylnitrosourea , Photoreceptor Cells, Vertebrate/drug effects , Photoreceptor Cells, Vertebrate/pathology , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Rats, Sprague-Dawley , Retina/drug effects , Retinal Degeneration/chemically induced , Retinal Degeneration/pathology , Reverse Transcriptase Polymerase Chain Reaction , bcl-2-Associated X Protein/metabolism
2.
Nan Fang Yi Ke Da Xue Xue Bao ; 26(5): 603-5, 2006 May.
Article in Chinese | MEDLINE | ID: mdl-16762860

ABSTRACT

OBJECTIVE: To observe the changes of nuclear factor-kappa B (NF-kappaB) in the course of N-methyl-N-nitrosourea (MNU)-induced apoptosis of rat retinal photoreceptor cells and investigate the mechanism of MNU-induced retinal damage. METHODS: A single intraperitoneal injection of 60 mg/kg MNU was given to 50-day-old female rats, which were sacrificed at different intervals after MNU treatment. The retinal damage was examined with optical microscopy and photoreceptor cell apoptosis detected by TUNEL assay. Western blotting was performed to analyze the changes in NF-kappaB. RESULTS: Pyknosis of the photoreceptor cell nuclei and disorientation of the outer segment of the photoreceptor layer was observed 24 h after MNU treatment, and the outer nuclear layer and photoreceptor layer were almost completely lost on day 7. Photoreceptor cell apoptosis peaked at 24 h, and in the apoptotic cascade, NF-kappaB p65 protein was only detected 12 and 24 h after MNU treatment, whereas the amount of I kappa B alpha, in contrast, markedly increased in the cytoplasm as well as in the nuclei. CONCLUSION: MNU-induced retinal damage might be mediated through the signaling pathway of NF-kappaB/I kappa B alpha.


Subject(s)
I-kappa B Proteins/metabolism , NF-kappa B/metabolism , Retinal Diseases/metabolism , Animals , Apoptosis/drug effects , Blotting, Western , Female , In Situ Nick-End Labeling , Methylnitrosourea/toxicity , Rats , Rats, Sprague-Dawley , Retinal Diseases/chemically induced , Retinal Diseases/pathology
3.
Yao Xue Xue Bao ; 40(8): 690-4, 2005 Aug.
Article in Chinese | MEDLINE | ID: mdl-16268501

ABSTRACT

AIM: To study the protective effect of ligustrazine against photoreceptor cell injury induced by N-methyl-N-nitrosourea (MNU) in Sprague-Dawley (SD) rats. METHODS: Ligustrazine injections of different doses were injected intraperitoneally into 47-day female SD rats once a day and a single intraperitoneal injection of MNU 60 mg x kg(-1) was given to 50-day rats. At different intervals after MNU treatment,the animals were sacrificed. The apoptotic index of photoreceptor cells was calculated by TUNEL labeling at 24 h following MNU treatment; peripheral retinal damage was evaluated based on retinal thickness at the d 7 after MNU treatment, and the expression of c-jun and c-fos genes was detected by RT-PCR technique. RESULTS: Ligustrazine injection could remarkably increase total thickness of peripheral retina and decrease apoptotic index of photoreceptor cells induced by MNU in a dose-dependent manner. Compared with MNU-treated rats, the gene expression of c-jun and c-fos was time-dependently down-regulated in ligustrazine-treated group. CONCLUSION: Ligustrazine injection partially protects against MNU-induced retinal damage by down-modulating the expression of c-jun and c-fos genes to inhibit apoptosis of photoreceptor cells.


Subject(s)
Apoptosis/drug effects , Ligusticum , Photoreceptor Cells/drug effects , Pyrazines/pharmacology , Retina , Animals , Dose-Response Relationship, Drug , Female , Genes, fos , Genes, jun , Injections, Intraperitoneal , Ligusticum/chemistry , Methylnitrosourea , Photoreceptor Cells, Vertebrate/drug effects , Photoreceptor Cells, Vertebrate/pathology , Plants, Medicinal/chemistry , Protective Agents/administration & dosage , Protective Agents/pharmacology , Pyrazines/administration & dosage , Pyrazines/isolation & purification , Rats , Rats, Sprague-Dawley , Retina/metabolism , Retina/pathology
4.
Chin Med J (Engl) ; 118(13): 1081-6, 2005 Jul 05.
Article in English | MEDLINE | ID: mdl-16098260

ABSTRACT

BACKGROUND: Previous studies have showed that photooxidative stress can lead to down-modulation of nuclear factor-kappa B (NF-kappaB) activity causing apoptosis of cultured photoreceptor cells. This study aimed at investigating whether NF-kappaB was involved in photoreceptor cells apoptosis induced by N-methyl-N-nitrosourea (MNU) in rats. METHODS: A single intraperitoneal injection of 60 mg/kg MNU was given to 50-day-old female rats. At different intervals after MNU treatment, the animals were sacrificed. Retinal damage was examined by a light microscope. The apoptotic index of the photoreceptor cells was detected by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling (TUNEL). NF-kappaB was analysed by Western blot and Transcriptin Factor Assay Kits. RESULTS: The pyknosis of the photoreceptor nuclei and the disorientation of the outer segment of the photoreceptor layer was seen after MNU treatment for 24 hours. The outer nuclear layer and photoreceptor layer were almost completely lost at 7 days. Photoreceptor cells apoptosis reached the peaked value at 24 hours. In apoptotic cascade, the protein levels of NF-kappaB p65 were only detected after MNU treatment for 12 and 24 hours in the nucleus. Conversely, the amounts of IkappaBalpha were markedly increased in the cytoplasm as well as in the nucleus. The activity of NF-kappaB p65 in the nucleus was down-modulated in the end. CONCLUSIONS: MNU-induced photoreceptor cell destruction was attributed to the apoptotic process by down-regulating the activation of NF-kappaB p65.


Subject(s)
Apoptosis/drug effects , Methylnitrosourea/toxicity , NF-kappa B/physiology , Photoreceptor Cells/drug effects , Animals , Cell Nucleus/metabolism , Female , I-kappa B Proteins/analysis , I-kappa B Proteins/physiology , NF-KappaB Inhibitor alpha , NF-kappa B/analysis , Photoreceptor Cells/chemistry , Photoreceptor Cells/pathology , Rats , Rats, Sprague-Dawley , Retina/drug effects , Retina/pathology
5.
Yao Xue Xue Bao ; 40(4): 306-10, 2005 Apr.
Article in Chinese | MEDLINE | ID: mdl-16011256

ABSTRACT

AIM: To study the effect of non-mitogenic human acidic fibroblast growth factor (nm-haFGF) on retinal injury induced by N-methyl-N-nitrosourea (MNU) in Sprague-Dawley rats and its mechanism. METHODS: Female rats of 50-days-old were injected with MNU (60 mg x kg(-1)) intraperitoneally, and three doses of nm-haFGF (1.25 microg, 2.5 microg and 5 microg in one eye of each rat) were injected, separately, into vitreous body of one eye of each rat twice a day at 0 and 12 h after MNU treatment. 24 h later, apoptotic index of photoreceptor cells was detected by TUNEL labeling and the expressions of Bcl-2 and Bax were analyzed by Western blotting. At the 7th day, retinal injury was evaluated based on retinal thickness. RESULTS: Compared with model group, apoptotic index of photoreceptor cells was significantly reduced in nm-haFGF groups at the dose of 1.25 microg and 2.5 microg in one eye of each rat at 24 h, and the total retinal thickness as well as the outer retinal thickness markedly increased 7 days after MNU, respectively. The expressions of Bcl-2 increased and that of Bax decreased adversely after being injected with different doses of nm-haFGF. CONCLUSION: nm-haFGF partially suppressed retinal injury induced by MNU in Sprague-Dawley rats. The mechanism could be related to up-regulation of Bcl-2 and down-regulation of Bax.


Subject(s)
Fibroblast Growth Factor 1/pharmacology , Proto-Oncogene Proteins c-bcl-2/metabolism , Retina/pathology , Retinitis Pigmentosa/pathology , bcl-2-Associated X Protein/metabolism , Animals , Apoptosis/drug effects , Female , Fibroblast Growth Factor 1/genetics , Methylnitrosourea , Photoreceptor Cells, Vertebrate/drug effects , Photoreceptor Cells, Vertebrate/pathology , Protective Agents/pharmacology , Random Allocation , Rats , Rats, Sprague-Dawley , Retina/drug effects , Retinitis Pigmentosa/chemically induced , Retinitis Pigmentosa/metabolism
6.
Acta Pharmacol Sin ; 26(7): 887-92, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15960898

ABSTRACT

AIM: To evaluate the effect of tetramethylpyrazine (TMP) injection on retinal damage induced by N-methyl-N-nitrosourea (MNU) in rats and on nuclear factor-kappa B (NF-kappaB) family members. METHODS: Female Sprague-Dawley (SD) rats were randomly divided into groups: (i), control group; (ii), model group; and (iii), TMP-injection groups, in which the rats were subdivided into 40 mg/kg, 80 mg/kg and 160 mg/kg groups. Drugs were injected ip into 47-day-old SD rats once a day. At 50 days of age, all rats in the model group and drug groups also received a single ip injection of 60 mg/kg MNU. Rats in group 1 received ip injection of physiological saline. All rats were killed at different times after MNU or physiological saline treatment. The apoptotic index of photoreceptor cells was calculated by TUNEL labeling; retinal damage was evaluated based on retinal thickness and the expression of NF-kappaB family members was detected by Western blot. RESULTS: TMP injections, in a dose-dependent manner, suppressed photoreceptor cell apoptosis and decreased its loss in the peripheral retina. As compared with the MNU-treated group, TMP injection at a dose of 160 mg/kg also time-dependently upregulated the NF-kappaB/p65 protein level in the nucleus and downregulated the IkappaBalpha protein level in the cytoplasm. However, no protective effect of TMP injection on MNU-induced central retinal damage was found. CONCLUSION: TMP injection partially protects against MNU-induced retinal damage by upregulating the nuclear translocation of p65 to inhibit photoreceptor cells apoptosis.


Subject(s)
Apoptosis/drug effects , Cell Nucleus/metabolism , Photoreceptor Cells, Vertebrate/pathology , Pyrazines/pharmacology , Transcription Factor RelA/metabolism , Animals , Cytoplasm/metabolism , Female , I-kappa B Proteins/metabolism , Ligusticum/chemistry , Methylnitrosourea , NF-KappaB Inhibitor alpha , Photoreceptor Cells, Vertebrate/metabolism , Plants, Medicinal/chemistry , Pyrazines/isolation & purification , Random Allocation , Rats , Rats, Sprague-Dawley , Retinal Diseases/chemically induced , Retinal Diseases/pathology
8.
Acta Pharmacol Sin ; 23(5): 461-6, 2002 May.
Article in English | MEDLINE | ID: mdl-11978198

ABSTRACT

AIM: To investigate the roles of caspases in diacetyldianhydrogalactitol (DADAG)-induced apoptosis in human leukemia HL-60 cells. METHODS: Inhibition of proliferation was measured by MTT assay. DADAG-induced apoptosis in HL-60 cells was observed by electron microscopy, flow cytometry, and DNA fragmentation assay. Caspase-3 activity was determined by ApoAlert CPP32 colorimetric assay kit. The cleavage of substrates of caspases was detected by Western blot. RESULTS: DADAG exhibited potent antiproliferative activity and induced apoptosis in HL-60 cells. After treatment with DADAG 8 mg/L for 24 h, caspase-3 activity increased markedly and the cleavage of poly-(ADP-ribose) polymerase (PARP), lamin B, and DFF45 appeared. All of the apoptotic signals were suppressed by z-VAD fmk (a general inhibitor of caspase activities), whereas z-DEVD fmk, a selective inhibitor of caspase-3 activity, only induced partial reversion of the apoptotic effects. CONCLUSION: DADAG induced apoptosis in HL-60 cells by activating caspases. Caspases promoted apoptosis through the cleavage of substrates of PARP, lamin B, and DFF45.


Subject(s)
Apoptosis , Caspases/metabolism , Dianhydrogalactitol/analogs & derivatives , Dianhydrogalactitol/pharmacology , Caspase 3 , Caspases/physiology , Cell Division/drug effects , HL-60 Cells , Humans , Leukemia/pathology
9.
Yao Xue Xue Bao ; 37(9): 691-5, 2002 Sep.
Article in Chinese | MEDLINE | ID: mdl-12567892

ABSTRACT

AIM: To investigate the apoptosis induced by diacetyldianhydrogalactitol (DADAG) and its mechanism in human HL-60 leukemia cells. METHODS: Inhibition of proliferation was measured by MTT assay. DADAG-induced apoptosis in HL-60 cells was observed by electron microscopy, flow cytometry and DNA fragmentation assay. The levels of Bcl-2 family proteins were detected by Western blotting. Caspase-3 activity was determined by ApoAlert CPP32 colorimetric assay kit. RESULTS: DADAG exhibited potent antiproliferative activity and induced apoptosis in HL-60 cells. After treatment with DADAG 8 micrograms.mL-1 for various times, the Bcl-XL protein level decreased in a time-dependent manner, while the Bad protein level was upregulated. The caspase-3 activity increased markedly after treatment with DADAG for 24 h. The apoptotic signals were suppressed by z-VAD.fmk (a general inhibitor of caspases), whereas z-DEVD.fmk, a selective inhibitor of caspase-3, only induced partial reversion of the apoptotic effects. CONCLUSION: DADAG-induced apoptosis in HL-60 cells required caspase-3 activation and caspase-3 activation was related with Bcl-2 family members.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis , Dianhydrogalactitol/analogs & derivatives , Dianhydrogalactitol/pharmacology , Caspase 3 , Caspases/metabolism , Cell Division/drug effects , HL-60 Cells , Humans , Proto-Oncogene Proteins c-bcl-2/metabolism , bcl-X Protein
SELECTION OF CITATIONS
SEARCH DETAIL